Extractions: This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor. Localized neuroaxonal dystrophy, late infantile neuroaxonal dystrophy, progressive pallidal degeneration syndrome, progressive pallidal degeneration or adult amaurotic idiocy, pigmentary degeneration syndrome of globus pallidus, substantia nigra and red nucleus, pallidoreticular pigment degeneration, progressive pallidal degeneration syndrome.
Redirect A clinical synopsis of hallervordenspatz syndrome. http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?234200
Hallervorden-Spatz Disease An article about HallervordenSpatz disease, with an explanation, the symptoms and prognosis. http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126
Hallervorden-Spatz Syndrome (www.whonamedit.com) hallervordenspatz syndrome A very rare disease with degeneration of the globus pallidus, red nucleus, and substantia nigra of the brain. It is http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126
Hallervorden-Spatz Syndrome Links to information and resources for hallervordenspatz syndrome, an inheritedneurological movement disorder. http://rarediseases.about.com/cs/hallervordenspatz/
Extractions: zJs=10 zJs=11 zJs=12 zJs=13 zc(5,'jsc',zJs,9999999,'') zfs=0;zCMt='a70' About Rare / Orphan Diseases Rare Diseases Essentials ... Help zau(256,140,140,'el','http://z.about.com/0/ip/417/C.htm','');w(xb+xb+' ');zau(256,140,140,'von','http://z.about.com/0/ip/496/6.htm','');w(xb+xb); Sign Up Now for the Rare / Orphan Diseases newsletter!
Extractions: National Institutes of Health The gene that causes Hallervorden-Spatz syndrome has been identified by National Eye Institute (NEI) grantees. Hallervorden-Spatz syndrome is a rare, inherited, neurological disorder associated with high accumulations of iron in the brain, and causes progressive degeneration of the retina and nervous system. The new findings appear in the August 2001 issue of Nature Genetics. Susan J. Hayflick, MD, associate professor of Molecular and Medical Genetics at Oregon Health Sciences University in Portland, and colleagues discovered that the defective gene produces an ineffective enzyme. The body needs the normal enzyme to utilize vitamin B5; without it, vitamin B5 cannot produce some of the body's essential compounds. The ineffective enzyme results in Hallervorden-Spatz syndrome. Because of this research, scientists can now focus their efforts on developing treatment strategies that bypass this defective enzyme, allowing the body to utilize vitamin B5 to help make the essential body compounds. Researchers can also look toward developing a genetic diagnostic test for the syndrome. Understanding the biochemical defects in Hallervorden-Spatz syndrome may also provide insights into the effect iron has on other neurodegenerative diseases associated with high iron accumulations, such as Parkinson's disease.
Hallervorden-Spatz Disease Neurodegeneration with Brain Iron Accumulation(HallervordenSpatz disease) information sheet compiled by the National Institute of Neurological http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126
Extractions: Authorizing Legislation: Section 301 of the Public Health Service Act, as amended. Reauthorizing legislation will be submitted. Budget Authority: 2001 Actual 2002 Appropriation 2002 Current Estimate 2003 Estimate Increase or Decrease Current Law BA Accured Costs Proposed Law BA FTE This document provides justification for the Fiscal Year 2003 activities of the National Eye Institute (NEI), including HIV/AIDS activities. A more detailed description of NIH-wide Fiscal Year 2003 HIV/AIDS activities can be found in the NIH section entitled "Office of AIDS Research (OAR). The President's appropriations request of $631,818,000 for this account includes current law adjusted by assuming Congressional action on the proposed Managerial Flexibility Act of 2001. Introduction TOP Story of Discovery Providing Sight to Dogs Born Blind.
Extractions: ADENOID CYSTIC CARCINOMA, MASTOCYTOSIS, HALLERVORDEN-SPATZ SYNDROME - NORD The National Organization for Rare Disorders is seeking applications for 1-year grants for clinical studies related to the early detection, diagnosis, or treatment of patients with 1) adenoid cystic carcinoma; 2) Hallervorden-Spatz syndrome; and 3) mastocytosis. Grants provide up to $30,000 for 1 year. Contact: NORD, Research Grant Program, 100 Rt. 37, P.O. Box 8923, New Fairfield, CT 06812-8923. Web: http://www.rarediseases.org/ E-mail: firstname.lastname@example.org Telephone: (800) 999-6673. Fax: (203) 746-6481. Deadline: 15 May 2002 for letters of intent; 1 August 2002 for invited full proposals. RSO Reference No.: